Meridian Healthcomms Holdings Limited
- Company number
- 11350918
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 9 May 2018
- Nature of business
- Activities of other holding companies n.e.c.
- Corporate group
- Bioscript Midco 2 Limited (13 companies)
Registered office
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Bioscript Limited | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
8 Apr 2022 | |
| Mr David Michael Anthony Andrews | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
9 May 2018 | 8 Apr 2022 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 30 Sep 2025 | - | - | - |
| 30 Sep 2024 | £1,572,873 | £25,640 | 0 |
| 30 Sep 2023 | £1,658,903 | £33,045 | 0 |
| 30 Sep 2022 | £1,697,367 | £37,461 | 0 |
| 31 Mar 2022 | £3,807,058 | £238,617 | 0 |
| 31 Mar 2021 | £2,860,103 | £135,487 | 0 |
| 31 Mar 2020 | £1,679,070 | £33,299 | 1 |
| 31 Mar 2019 | £494,750 | £12,879 | - |
Connections
Owned by
Meridian Healthcomms Holdings Limited → Bioscript Limited → Bioscript Midco 2 Limited
Controls
- Cancer Communications And Consultancy Limited (05049252)
- Meridian Healthcomms Limited (05125119)
Companies at the same address
- Azimuth Pharma Limited (07916512)
- Bioscript Group Limited (09542360)
- Bioscript Holdings Limited (13203898)
- Bioscript Limited (13216692)
- Bioscript Midco 1 Limited (13208513)
- Bioscript Midco 2 Limited (13212966)
- Bioscript Stirling Limited (04354625)
- Cancer Communications And Consultancy Limited (05049252)
- Enzyme Communications Ltd (10790509)
- Fortis Pharma Consulting Limited (05390470)